"This report studies the Prostaglandin market. Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax." Scope of the Report: This report focuses on the Prostaglandin in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application. Market Segment by Manufacturers, this report covers CEPIA Johnson Matthey Pfizer Cayman Chemical EMD Millipore Yonsung Fine Chemicals Everlight Chemical Piramal Enterprises Bio-Techne Corporation Mironova Labs Chirogate Market Segment by Countries, covering United States Canada Mexico Market Segment by Type, covers Human Prostaglandin Veterinary Prostaglandin Market Segment by Applications, can be divided into Cardiovascular Digestive Gynecological and Obstetrical Ophthalmologic Other There are 15 Chapters to deeply display the North America Prostaglandin market. Chapter 1, to describe Prostaglandin Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Prostaglandin, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Prostaglandin, for each country, from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017; Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications; Chapter 10, Prostaglandin market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022; Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 13, to describe sales channel, distributors, traders, dealers etc. Chapter 14 and 15, to describe Prostaglandin Research Findings and Conclusion, Appendix, methodology and data source
Table of Contents 1 Market Overview 1.1 Prostaglandin Introduction 1.2 Market Analysis by Type 1.2.1 Human Prostaglandin 1.2.2 Veterinary Prostaglandin 1.3 Market Analysis by Applications 1.3.1 Cardiovascular 1.3.2 Digestive 1.3.3 Gynecological and Obstetrical 1.3.4 Ophthalmologic 1.3.5 Other 1.4 Market Analysis by
